10-Q Filing

CVS HEALTH CORP CIK: 64803 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0000064803-23-000047`
Period End Date	20230930
Filing Date	20231101
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	cvs-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 108 Income Statement 97 Cash Flow Statement 96 Stockholders Equity 85 Comprehensive Income 48

Balance Sheet 108 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.95B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.04B	USD	Point-in-time
Investments	`ShortTermInvestments`	$3.15B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.78B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$27.28B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$32.93B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$17.95B	USD	Point-in-time
Inventories	`InventoryNet`	$19.09B	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$908.00M	USD	Point-in-time
Assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$3.07B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.64B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.77B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.76B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$65.63B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.29B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$70.14B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	480.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$21.67B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$21.10B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$13.02B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.87B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.87B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$17.56B	USD	Point-in-time
Goodwill	`Goodwill`	$78.15B	USD	Point-in-time
Goodwill	`Goodwill`	$91.26B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$24.80B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$29.62B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.23B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.20B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.83B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.62B	USD	Point-in-time
Total assets	`Assets`	$228.28B	USD	Point-in-time
Total assets	`Assets`	$251.31B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$14.84B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$14.87B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$21.50B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsAndDiscountsPayableCurrent`	$19.42B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$10.14B	USD	Point-in-time
Health care costs payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$12.55B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.44B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$1.50B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$18.75B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$22.57B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.09B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$4.75B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.74B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.68B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$2.13B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$1.78B	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$228.00M	USD	Point-in-time
Liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$81.55B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$69.42B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$16.80B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$16.44B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$59.78B	USD	Point-in-time
Long-term debt	`LongTermDebtAndCapitalLeaseObligations`	$50.48B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.02B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$4.25B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.20B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$5.09B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.23B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.32B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$5.83B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$5.33B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.24B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$6.73B	USD	Point-in-time
Total liabilities	`Liabilities`	$156.51B	USD	Point-in-time
Total liabilities	`Liabilities`	$176.80B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,767 shares issued and 1,287 shares outstanding at September 30, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.83B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,767 shares issued and 1,287 shares outstanding at September 30, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$48.19B	USD	Point-in-time
Treasury stock, at cost: 480 shares at September 30, 2023 and 458 shares at December 31, 2022	`TreasuryStockCommonValue`	$31.86B	USD	Point-in-time
Treasury stock, at cost: 480 shares at September 30, 2023 and 458 shares at December 31, 2022	`TreasuryStockCommonValue`	$33.83B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$60.34B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$56.40B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.26B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.00B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$71.47B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$74.34B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$300.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$173.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.49B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.00B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.74B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.51B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$251.31B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$228.28B	USD	Point-in-time

Income Statement 97 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$21.00B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$24.66B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$74.12B	USD	3 Qtrs
Premiums	`PremiumsEarnedNet`	$63.89B	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$515.00M	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$885.00M	USD	3 Qtrs
Net investment income	`NetInvestmentIncome`	$277.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$201.00M	USD	1 Quarter
Total revenues	`Revenues`	$263.96B	USD	3 Qtrs
Total revenues	`Revenues`	$238.62B	USD	3 Qtrs
Total revenues	`Revenues`	$81.16B	USD	1 Quarter
Total revenues	`Revenues`	$89.76B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$50.37B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$159.68B	USD	3 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$54.69B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$145.16B	USD	3 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$52.81B	USD	3 Qtrs
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$21.50B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$17.40B	USD	1 Quarter
Health care costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$63.73B	USD	3 Qtrs
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	$11.00M	USD	1 Quarter
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	3 Qtrs
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	-	USD	1 Quarter
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	$507.00M	USD	3 Qtrs
Restructuring charges	`RestructuringCostsAndAssetImpairmentCharges`	$496.00M	USD	1 Quarter
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	$-5.70B	USD	3 Qtrs
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	$-5.22B	USD	1 Quarter
Opioid litigation charges	`GainLossRelatedToLitigationSettlement`	-	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.52B	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.48B	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$349.00M	USD	3 Qtrs
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$29.33B	USD	3 Qtrs
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$9.61B	USD	1 Quarter
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$28.12B	USD	3 Qtrs
Operating expenses	`OperatingExpensesExcludingGoodwillImpairmentsLossOnAssetsHeldForSaleAndLossOnLitigationSettlement`	$9.88B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$86.07B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$234.33B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$253.59B	USD	3 Qtrs
Total operating costs	`CostsAndExpenses`	$85.08B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$4.29B	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$10.37B	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$3.69B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-3.92B	USD	1 Quarter
Interest expense	`InterestExpense`	$1.97B	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.74B	USD	3 Qtrs
Interest expense	`InterestExpense`	$566.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$693.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$22.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$126.00M	USD	3 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$41.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$66.00M	USD	3 Qtrs
Income (loss) before income tax provision (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$8.47B	USD	3 Qtrs
Income (loss) before income tax provision (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.69B	USD	3 Qtrs
Income (loss) before income tax provision (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$3.02B	USD	1 Quarter
Income (loss) before income tax provision (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-4.44B	USD	1 Quarter
Income tax provision (benefit)	`IncomeTaxExpenseBenefit`	$2.15B	USD	3 Qtrs
Income tax provision (benefit)	`IncomeTaxExpenseBenefit`	$754.00M	USD	1 Quarter
Income tax provision (benefit)	`IncomeTaxExpenseBenefit`	$-1.04B	USD	1 Quarter
Income tax provision (benefit)	`IncomeTaxExpenseBenefit`	$691.00M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-3.40B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.04B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.91B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.27B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.32B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.00B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.35B	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$18.00M	USD	3 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$23.00M	USD	3 Qtrs
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$6.30B	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$1.98B	USD	3 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-3.41B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$2.26B	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$4.90	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-2.59	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.76	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.51	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.75	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.59	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.49	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$4.88	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.28B	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.29B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.29B	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.29B	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.32B	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.55	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.60	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.81	USD	3 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.65	USD	3 Qtrs

Cash Flow Statement 96 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$260.30B	USD	3 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$235.40B	USD	3 Qtrs
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$153.05B	USD	3 Qtrs
Cash paid for inventory, prescriptions dispensed and health services rendered	`PaymentsForInventoryAndPrescriptionsDispensedByRetailNetworkPharmacies`	$138.78B	USD	3 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$51.43B	USD	3 Qtrs
Insurance benefits paid	`PaymentsForInsuranceBenefits`	$61.66B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$26.04B	USD	3 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$22.73B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$1.17B	USD	3 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$687.00M	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$2.05B	USD	3 Qtrs
Interest paid	`InterestPaidNet`	$1.94B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$2.62B	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$3.07B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.06B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.13B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.54B	USD	3 Qtrs
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$5.55B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$6.62B	USD	3 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$6.44B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.12B	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.04B	USD	3 Qtrs
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$16.49B	USD	3 Qtrs
Acquisitions (net of cash and restricted cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$131.00M	USD	3 Qtrs
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,808 in 2022)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$-1.93B	USD	3 Qtrs
Proceeds from sale of subsidiaries (net of cash and restricted cash sold of $2,808 in 2022)	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-74.00M	USD	3 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-43.00M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-4.93B	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-19.65B	USD	3 Qtrs
Proceeds from issuance of short-term loan	`ProceedsFromOtherShortTermDebt`	$5.00B	USD	3 Qtrs
Proceeds from issuance of short-term loan	`ProceedsFromOtherShortTermDebt`	-	USD	3 Qtrs
Repayment of short-term loan	`RepaymentsOfOtherShortTermDebt`	$5.00B	USD	3 Qtrs
Repayment of short-term loan	`RepaymentsOfOtherShortTermDebt`	-	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$10.90B	USD	3 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$4.20B	USD	3 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$2.73B	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.01B	USD	3 Qtrs
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$2.00B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$2.19B	USD	3 Qtrs
Dividends paid	`PaymentsOfDividends`	$2.35B	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$242.00M	USD	3 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$510.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$175.00M	USD	3 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$337.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-210.00M	USD	3 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-119.00M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.65B	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-8.33B	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$70.00M	USD	3 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.87B	USD	3 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.38B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.56B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.30B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.38B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$12.69B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$17.56B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$13.30B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-3.40B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.04B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.91B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.27B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.32B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.00B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.35B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.23B	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.18B	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	-	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.52B	USD	3 Qtrs
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.48B	USD	1 Quarter
Loss on assets held for sale	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$349.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$461.00M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$341.00M	USD	3 Qtrs
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	3 Qtrs
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Gain on sale of subsidiary	`GainLossOnSaleOfBusiness`	$225.00M	USD	3 Qtrs
Deferred income taxes and other noncash items	`DeferredIncomeTaxesAndOtherNoncashItems`	$-2.21B	USD	3 Qtrs
Deferred income taxes and other noncash items	`DeferredIncomeTaxesAndOtherNoncashItems`	$-360.00M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$3.92B	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.01B	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-1.30B	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$415.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$244.00M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$518.00M	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$3.35B	USD	3 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$2.47B	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$4.68B	USD	3 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$4.48B	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$7.37B	USD	3 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$2.05B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$16.06B	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$18.13B	USD	3 Qtrs

Stockholders Equity 85 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldInTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Common stock	`CommonStockValue`	$18.00M	USD	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	480.00M	shares	Point-in-time
Treasury shares outstanding, balance at beginning of period (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.49B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.00B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.74B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.51B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-3.40B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.04B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.91B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.27B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.32B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.00B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.35B	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$17.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.69B	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-763.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$389.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-385.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-540.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-146.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$260.00M	USD	3 Qtrs
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$197.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$173.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$165.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$122.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$345.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$300.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$129.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$267.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.97B	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$1.96B	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$105.00M	USD	1 Quarter
ESPP issuances, net of purchase of treasury shares	`ESPPIssuanceNetOfTreasuryStockValueAcquiredCostMethod`	$86.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$723.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$786.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$786.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$730.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$781.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$729.00M	USD	1 Quarter
Acquisition of noncontrolling interests	`NoncontrollingInterestIncreaseFromBusinessCombination`	$66.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-5.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-95.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$3.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$2.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-1.00M	USD	1 Quarter
Other increases (decreases) in noncontrolling interests	`NoncontrollingInterestOtherPeriodIncreaseDecrease`	$-99.00M	USD	1 Quarter
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	480.00M	shares	Point-in-time
Treasury shares outstanding, balance at end of period (in shares)	`TreasuryStockCommonShares`	458.00M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.49B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.58B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$71.77B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$73.00B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.74B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.03B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$75.38B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$74.51B	USD	Point-in-time

Comprehensive Income 48 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-3.40B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.04B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$1.91B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.27B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$2.14B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$6.32B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.00B	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$2.35B	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$85.00M	USD	3 Qtrs
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-2.63B	USD	3 Qtrs
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-637.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-321.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$250.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$929.00M	USD	3 Qtrs
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$181.00M	USD	1 Quarter
Change in discount rate on long-duration insurance reserves	`OciLiabilityForFuturePolicyBenefitGainLossAfterReclassificationAdjustmentAndTax`	$167.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-5.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-7.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$9.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$8.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$20.00M	USD	3 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-1.00M	USD	1 Quarter
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-2.00M	USD	3 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	3 Qtrs
Pension and other postretirement benefits	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	-	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$17.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.69B	USD	3 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-763.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$389.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-385.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-540.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-146.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$260.00M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$307.00M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-3.78B	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$6.58B	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.12B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$18.00M	USD	3 Qtrs
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$23.00M	USD	3 Qtrs
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$4.00M	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$2.12B	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-3.79B	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$289.00M	USD	3 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$6.56B	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.